Comparison of 2 real-time PCR assays for diagnosis of Pneumocystis jirovecii pneumonia in human immunodeficiency virus (HIV) and non-HIV immunocompromised patients

Diagnostic Microbiology and Infectious Disease

Volumn 82, Issue 2, 2015, Pages 143-147

  Montesinos, Isabel ^a   Brancart, Françoise ^a   Schepers, Kinda ^a   Jacobs, Frederique ^a   Denis, Olivier ^a   Delforge, Marie Luce ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Pneumocystis jirovecii pneumonia; Quantitative real time PCR

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA EXTRACTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; INTERMETHOD COMPARISON; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MOLECULAR DIAGNOSIS; NONHUMAN; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; BRONCHOALVEOLAR LAVAGE FLUID; COMPLICATION; GENETICS; IMMUNOCOMPROMIZED PATIENT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS; PROCEDURES;

BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84929044883     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2015.03.006     Document Type: Article

References (26)

1. Alanio A., Desoubeaux G., Sarfati C., Hamane S., Bergeron A., Azoulay E., et al. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clin Microbiol Infect 2011, 17:1531-1537.
2. Botterel F., Cabaret O., Foulet F., Cordonnier C., Costa J.M., Bretagne S. Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage specimens from immunocompromised patients. J Clin Microbiol 2012, 50:227-231.
3. Brancart F., Rodriguez-Villalobos H., Fonteyne P.A., Peres-Bota D., Liesnard C. Quantitative TaqMan PCR for detection of Pneumocystis jirovecii. J Microbiol Methods 2005, 61:381-387.
4. Damiani C., Le Gal S., Da Costa C., Virmaux M., Nevez G., Totet A. Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-beta D-glucan for differential diagnosis of Pneumocystis pneumonia and Pneumocystis colonization. J Clin Microbiol 2013, 51:3380-3388.
5. Durand-Joly I., Chabé M., Soula F., Delhaes L., Calus D., Dei-Cas E. Molecular diagnosis of Pneumocystis pneumonia. FEMS Immunol Med Microbiol 2005, 45:405-410.
6. Fillatre P., Chevrier S., Revest M., Gacouin A., Jouneau S., Leroy H., et al. Human herpes virus co-infection is associated with mortality in HIV-negative patients with Pneumocystis jirovecii pneumonia. Eur J Clin Microbiol Infect Dis 2013, 32:189-194.
7. Flori P., Bellete B., Durand F., Raberin H., Cazorla C., Hafid J., et al. Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jirovecii pneumonia from bronchoalveolar lavage specimens. J Med Microbiol 2004, 53:603-607.
8. Gutierrez S., Respaldiza N., Campano E., Martínez-Risquez M.T., Calderón E.J., De La Horra C. Pneumocystis jirovecii colonization in chronic pulmonary disease. Parasite 2011, 18:121-126.
9. Hauser P., Bille J., Lass-Flörl C., Geltner C., Feldmesser M., Levi M., et al. Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk of Pneumocystis jirovecii infection by use of a commercial real-time PCR assay. J Clin Microbiol 2011, 49:1872-1878.
10. Kaplan J.E., Hadson D., Dworkin M.S., Frederick T., Bertolli J., Lindegren M.L., et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000, 30:S5-S14.
11. Li M.C., Lee N.Y., Lee C.C., Lee H.C., Chang C.M., Ko W.C. Pneumocystis jirovecii pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals. J Microbiol Immunol Infect 2014, 47:42-47.
12. Maillet M., Maubon D., Brion J.P., François P., Molina L., Stahl J.P., et al. Pneumocystis jirovecii (PJ) quantitative PCR to differentiate PJ pneumonia from PJ colonization in immunocompromised patients. Eur J Clin Microbiol Dis 2014, 33:331-336.
13. Martin S.I., Fishman J.A. Pneumocystis pneumonia in solid organ transplantation. Am J Transplant 2013, 13:272-279.
14. Matsumura Y., Ito Y., Iinuma Y.M., Yamamoto A., Matsushima M., Nagao S., et al. Quantitative real-time PCR and the (1-3)-β-D-glucan assay for differentiation between active Pneumocystis jirovecii pneumonia and colonization. Clin Microbiol Infect 2012, 18:591-597.
15. McTaggart L.R., Wengenack N.L., Richardson S.E. Validation of the MycAssay Pneumocystis Kit for detection of Pneumocystis jirovecii in bronchoalveolar lavage specimens in comparison to a laboratory standard of direct immunofluorescence microscopy, real-time PCR, or conventional PCR. J Clin Microbiol 2012, 50:1856-1859.
16. Morris A., Wei K., Afshar K., Huang L. Epidemiology and clinical significance of Pneumocystis colonization. J Infect Dis 2008, 197:10-17.
17. Nüesch R., Bellini C., Zimmerli W. Pneumocystis carinii pneumonia in human immunodeficiency virus (HIV)-positive and HIV-negative immunocompromised patients. Clin Infect Dis 1999, 29:1519-1523.
18. Orsi C., Gennari W., Venturelli C., La Regina A., Pecorari M., Righi E., et al. Performance of 2 commercial real-time PCR assays for the detection of Aspergillus and Pneumocystis DNA in bronchoalveolar lavage fluid samples from critical care patients. Diagnostic Microbiol Infect Dis 2012, 73:138-143.
19. Procop G.W., Haddad S., Quinn J., Wilson M.L., Henshaw N.G., Reller L.B., et al. Detection of Pneumocystis jirovecii in respiratory specimens by four staining methods. J Clin Microbiol 2004, 42:3333-3335.
20. Ribes J.A., Limper A.H., Espy M.J., Smith T.F. PCR detection of Pneumocystis carinii in bronchoalveolar lavage specimens: analysis of sensitivity and specificity. J Clin Microbiol 1997, 35:830-835.
21. Robert-Gangneux F., Delaz S., Revest M., Tattevin P., Jouneau S., Deacaux O., et al. Diagnosis of Pneumocystis carinii pneumonia in immunocompromised patients by real-time PCR: a 4 year prospective study. J Clin Microbiol 2014, 52:3370-3376.
22. Roblot F., Godet C., Le Moal G., Garo B., Faouzi Souala M., Dary M., et al. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis 2002, 21:523-531.
23. Sing A., Roggenkamp A., Autenrieth I.B., Heeseman J. Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR. J Clin Microbiol 1999, 32:3409-3410.
24. Tasaka S., Tokuda H. Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies. J Infect Chemother 2012, 18:793-806.
25. Tia T., Putaporntip C., Kosuwin R., Kongpolprom N., Kawkitinarong K., Jongwutiwes S. A highly sensitive novel PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage specimens from immunocompromised patients. Clin Microbiol Infect 2012, 18:598-603.
26. Walzer P.D., Evans H.E., Copas A.J., Edwards S.G., Grant A.D., Miller R.F. Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006. Clin Infect Dis 2008, 46:625-633.